Convergence and Personalized MedicineByAZBio Members
Published: 2013-05-17 19:31:59
Greg Yap is Senior Vice President and Lifecycle Leader for
Advanced Staining Assays at Ventana Medical Systems.
In this role, Greg is responsible for Ventana’s 450 million dollar cancer diagnostic testing business. Ventana’s tests are the market leaders and are used to help guide treatment for over 6 million cancer patients each year worldwide. Previously, Greg was Chief Operating Officer at Cellective Dx, a circulating tumor cell company, and held multiple senior operating roles at Affymetrix.